#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma malignant Phenylketonuria Familial haemophagocytic lymphohistiocytosis Arterial tortuosity syndrome Polycythaemia vera Wiskott-Aldrich syndrome Leukocyte adhesion deficiency type I Netherton's syndrome Non-Hodgkin's lymphoma unspecified histology indolent Deafness bilateral Lymphoma Acquired ATTR amyloidosis Hepatocellular carcinoma Drug eruption Synovial sarcoma More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Basic Information Malignant fibrous histiocytoma – Treatment Haemophilia A with anti factor VIII Vascular malformation – Basic Information Small intestine leiomyosarcoma – Trials in Disease Glycogen storage disease type I – Life with Disease MELAS syndrome Langerhans cell sarcoma – Trials in Disease Short-bowel syndrome Mantle cell lymphoma stage II – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Ascorbic Acid Ifezuntirgene Inilparvovec Lolium Perenne Anhydrous Cidofovir Ck-0045 L-Tyrosine Ursodoxicoltaurine ARFOLITIXORIN Rilzabrutinib Bi-1808 NALMEFENE HYDROCHLORIDE Ciclosporin A Oxygen Ph.eur. Emactuzumab E2814 Varnimcabtagene Autoleucel Hypromellose Transcon Il-2Β/Γ Teriparatide Zidesamtinib More therapies…

    Learn about Your Condition

    Cutaneous calcification Muscular dystrophy Inner ear disorder Bipolar disorder Follicular lymphoma stage III HER2 protein overexpression Ligament sprain Still's disease Choreoathetosis Bone marrow failure Cognitive disorder Notalgia paraesthetica Childhood asthma Spinal pain Endocrine ophthalmopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Lenalidomide
    • Tocilizumab
    France Spain

  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    • Fallopian tube cancer
    Investigated Drugs:
    • Raludotatug Deruxtecan
    • Doxorubicin Hydrochloride, Liposomal
    • Paclitaxel
    Czechia Finland France Germany Greece Italy +3

  • Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pf-06835375
    • Diphenhydramine Hydrochloride
    Czechia Hungary Poland

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Irbesartan
    • Amlodipine
    Greece

  • Study of Zolbetuximab with Nab-Paclitaxel and Gemcitabine for Adults with Metastatic Pancreatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Zolbetuximab
    • Gemcitabine
    • Paclitaxel
    France Ireland Italy Spain

  • Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Seladelpar
    Austria Belgium Czechia France Germany Greece +6
Previous Page
1 … 1,689 1,690 1,691 1,692 1,693 … 1,695
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!